 CARLSBAD, Calif. , Sept. 8, 2022 PRNewswire -- Tyra Biosciences, Inc. Nasdaq: TYRA, a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that management will participate at the following investor conferences: H.C. 